Author:
El-Shakankery Karim Hussien,Kefas Joanna,Crusz Shanthini Mary
Abstract
SummaryIn response to our current global pandemic, unprecedented healthcare changes may have significant consequences for cancer patients in the United Kingdom. We explore why cancer patients may be more susceptible to severe infection and complications, highlighting various interventions that may help to ensure continuity of care in this unique cohort.
Publisher
Springer Science and Business Media LLC
Reference10 articles.
1. Wood, L. DHSC issues guidance on the impact of COVID-19 on research funded or supported by NIHR. https://www.nihr.ac.uk/news/dhsc-issues-guidance-on-the-impact-on-covid-19-on-research-funded-or-supported-by-nihr/24469 (2020).
2. Liang, W., Guan, W., Chen, R., Wang, W., Li, J., Xu, K. et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 21, 335–337 (2020).
3. Crawford, J., Dale, D. & Lyman, G. Chemotherapy-induced neutropenia. Cancer 100, 228–237 (2004).
4. Sleijfer, S. Bleomycin-induced pneumonitis. Chest 120, 617–624 (2004).
5. Abdel-Rahman, O. & Fouad, M. Risk of pneumonitis in cancer patients treated with immune checkpoint inhibitors: a meta-analysis. Ther. Adv. Respir. Dis. 10, 183–193 (2016).
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献